JP2022508619A5 - - Google Patents
Info
- Publication number
- JP2022508619A5 JP2022508619A5 JP2021543982A JP2021543982A JP2022508619A5 JP 2022508619 A5 JP2022508619 A5 JP 2022508619A5 JP 2021543982 A JP2021543982 A JP 2021543982A JP 2021543982 A JP2021543982 A JP 2021543982A JP 2022508619 A5 JP2022508619 A5 JP 2022508619A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- protein
- disorder
- nmb
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024175317A JP2025000998A (ja) | 2018-10-04 | 2024-10-04 | ニューロメジンペプチドを使用して２型サイトカイン媒介性炎症を低減させる方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862741188P | 2018-10-04 | 2018-10-04 | |
| US62/741,188 | 2018-10-04 | ||
| PCT/US2019/054546 WO2020072805A1 (en) | 2018-10-04 | 2019-10-03 | Methods of reducing type 2 cytokine-mediated inflammation using neuromedin peptides |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024175317A Division JP2025000998A (ja) | 2018-10-04 | 2024-10-04 | ニューロメジンペプチドを使用して２型サイトカイン媒介性炎症を低減させる方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022508619A JP2022508619A (ja) | 2022-01-19 |
| JP2022508619A5 true JP2022508619A5 (cg-RX-API-DMAC10.html) | 2022-10-11 |
Family
ID=70054870
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021543982A Pending JP2022508619A (ja) | 2018-10-04 | 2019-10-03 | ニューロメジンペプチドを使用して２型サイトカイン媒介性炎症を低減させる方法 |
| JP2024175317A Pending JP2025000998A (ja) | 2018-10-04 | 2024-10-04 | ニューロメジンペプチドを使用して２型サイトカイン媒介性炎症を低減させる方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024175317A Pending JP2025000998A (ja) | 2018-10-04 | 2024-10-04 | ニューロメジンペプチドを使用して２型サイトカイン媒介性炎症を低減させる方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20210346462A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3860635A4 (cg-RX-API-DMAC10.html) |
| JP (2) | JP2022508619A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20210095132A (cg-RX-API-DMAC10.html) |
| CN (1) | CN113164552B (cg-RX-API-DMAC10.html) |
| CA (1) | CA3114911A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2020072805A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102634568B1 (ko) * | 2021-10-08 | 2024-02-08 | 재단법인 아산사회복지재단 | 천식과 copd 구별용 바이오마커 조성물 및 이를 이용한 천식과 copd의 구별 방법 |
| CN120795118B (zh) * | 2025-06-27 | 2026-07-03 | 江苏省家禽科学研究所 | 一种鸭神经介素b修饰多肽及其多克隆抗体制备方法和应用 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3854480A (en) | 1969-04-01 | 1974-12-17 | Alza Corp | Drug-delivery system |
| US3832253A (en) | 1973-03-21 | 1974-08-27 | Baxter Laboratories Inc | Method of making an inflatable balloon catheter |
| US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
| US4667014A (en) | 1983-03-07 | 1987-05-19 | Syntex (U.S.A.) Inc. | Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists |
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US4452775A (en) | 1982-12-03 | 1984-06-05 | Syntex (U.S.A.) Inc. | Cholesterol matrix delivery system for sustained release of macromolecules |
| CA1200416A (en) | 1983-05-13 | 1986-02-11 | Societe Des Produits Nestle S.A. | Food process |
| IT1164225B (it) | 1983-05-13 | 1987-04-08 | Anic Spa | Analoghi retro-invertiti del pentapeptide potenziante la bradichina bpp5a e metodi per la loro preparazione |
| US5075109A (en) | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
| WO1991004040A1 (en) * | 1989-09-15 | 1991-04-04 | Biomeasure, Inc. | Treatment of colon cancer |
| US5217955A (en) * | 1989-09-15 | 1993-06-08 | Biomeasure, Inc. | Treatment of cancer with peptide analog of bombesin, grp, litorin or neuromedin |
| JPH04167172A (ja) | 1990-10-31 | 1992-06-15 | Nec Corp | ベクトルプロセッサ |
| KR100201352B1 (ko) | 1995-03-16 | 1999-06-15 | 성재갑 | 단일주사 백신 제형 |
| US6218371B1 (en) | 1998-04-03 | 2001-04-17 | University Of Iowa Research Foundation | Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines |
| WO2000001720A2 (en) | 1998-07-02 | 2000-01-13 | President And Fellows Of Harvard College | Compositions and methods for treating papillomavirus-infected cells |
| EP1146121A1 (en) * | 2000-04-14 | 2001-10-17 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Method for modification of proteins by transglutaminase |
| IL155773A0 (en) * | 2000-12-20 | 2003-12-23 | Warner Lambert Co | Novel uses of non-peptide bombesin receptor antagonists for treating anxiety and panic disorders |
| US7081489B2 (en) | 2001-08-09 | 2006-07-25 | Florida State University Research Foundation | Polymeric encapsulation of nanoparticles |
| US6780324B2 (en) | 2002-03-18 | 2004-08-24 | Labopharm, Inc. | Preparation of sterile stabilized nanodispersions |
| EP1583473A2 (en) | 2003-01-16 | 2005-10-12 | St. Johns University New York | Nanoparticle based stabilization of ir fluorescent dyes |
| WO2006052285A2 (en) | 2004-05-13 | 2006-05-18 | The Trustees Of Columbia University In The City Of New York | Polymeric nanoparticles and nanogels for extraction and release of compounds |
| US7342048B2 (en) | 2005-04-28 | 2008-03-11 | Nipro Corporation | Bioabsorbable pharmaceutical formulation |
| EP1906985A4 (en) | 2005-05-10 | 2012-07-11 | Naomi Balaban | COMPOSITIONS FOR ADMINISTERING RNAIII-INHIBITING PEPTIDES |
| US20070065367A1 (en) | 2005-09-20 | 2007-03-22 | Rany Condos | Method of treating pulmonary disease with interferons |
| GB0613925D0 (en) | 2006-07-13 | 2006-08-23 | Unilever Plc | Improvements relating to nanodispersions |
| AU2008303928A1 (en) | 2007-09-11 | 2009-04-02 | Mondobiotech Laboratories Ag | Use of NF-KAPPAB inhibitor SN50 and optionally angiotensin III as therapeutic agents in the treatment of EG HBV infection |
| DK3105317T3 (en) * | 2014-02-14 | 2019-01-14 | Cellectis | Immunotherapy cells that are genetically engineered to target antigen on both immune cells and pathological cells |
| KR102385120B1 (ko) * | 2014-03-31 | 2022-04-12 | 한미약품 주식회사 | 면역글로불린 Fc 단편 결합을 이용한 단백질 및 펩타이드의 용해도를 개선시키는 방법 |
| US10261098B2 (en) * | 2014-08-18 | 2019-04-16 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Biomarkers for diagnosis and management of neuro-immunological diseases |
| EP3490542A4 (en) * | 2016-07-26 | 2020-07-08 | Flagship Pioneering Innovations V, Inc. | NEUROMODULATION COMPOSITIONS AND RELATED THERAPEUTIC METHODS FOR THE TREATMENT OF CANCER BY MODULATION OF AN ANTI-CANCER RESPONSE |
-
2019
- 2019-10-03 EP EP19869376.4A patent/EP3860635A4/en active Pending
- 2019-10-03 KR KR1020217013463A patent/KR20210095132A/ko not_active Ceased
- 2019-10-03 WO PCT/US2019/054546 patent/WO2020072805A1/en not_active Ceased
- 2019-10-03 CN CN201980080467.2A patent/CN113164552B/zh active Active
- 2019-10-03 JP JP2021543982A patent/JP2022508619A/ja active Pending
- 2019-10-03 US US17/282,883 patent/US20210346462A1/en not_active Abandoned
- 2019-10-03 CA CA3114911A patent/CA3114911A1/en active Pending
-
2024
- 2024-10-04 JP JP2024175317A patent/JP2025000998A/ja active Pending
-
2026
- 2026-02-06 US US19/532,862 patent/US20260174829A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Park et al. | mRNA vaccines for COVID-19: what, why and how | |
| JP2022507454A5 (cg-RX-API-DMAC10.html) | ||
| JP2025114562A (ja) | 非組み込みウイルス送達システムおよびその使用の方法 | |
| JP2016128513A5 (cg-RX-API-DMAC10.html) | ||
| JP2017513956A (ja) | 核酸ワクチン | |
| EP3043826A1 (en) | Polynucleotide compositions containing amino acids | |
| McLachlan et al. | Progress in respiratory gene therapy | |
| JP2021525707A5 (cg-RX-API-DMAC10.html) | ||
| CN113072623B (zh) | 一种靶向SARS-CoV-2 N蛋白的干扰肽的制备方法及应用 | |
| CN103372199B (zh) | 一种预防和治疗神经退行性疾病的新型脑部靶向制剂 | |
| JP2020530765A5 (cg-RX-API-DMAC10.html) | ||
| JP2023542297A5 (cg-RX-API-DMAC10.html) | ||
| WO2023051701A1 (zh) | 抗SARS-CoV-2感染的mRNA、蛋白以及抗SARS-CoV-2感染的疫苗 | |
| JP2015513550A (ja) | Ｊｃｖ−ｖｌｐに基づく新規薬物送達系 | |
| JP2021528407A5 (cg-RX-API-DMAC10.html) | ||
| WO2021228052A1 (zh) | 生物大分子靶向特异性补体抑制剂及其制备方法与应用 | |
| CN104168910B (zh) | 肽及其用途 | |
| JP2021533821A (ja) | 組換え核酸コンストラクト | |
| Zeitlin | Future pharmacological treatment of cystic fibrosis | |
| He et al. | C-fiber degeneration enhances alveolar macrophage-mediated IFN-α/β response to respiratory syncytial virus | |
| CN116003524A (zh) | 一种靶向cGAS的短肽、融合多肽及应用 | |
| CN120518738A (zh) | 具有心脏保护活性的蛋白质 | |
| JP2024523329A5 (cg-RX-API-DMAC10.html) | ||
| RU2012146542A (ru) | Способ ингибирования репликации вич в клетках млекопитающих и у людей | |
| JP2021521193A5 (cg-RX-API-DMAC10.html) |